Your browser doesn't support javascript.
loading
Study of the Efficacy of Uptitrating Teneligliptin Dose from Standard Dose (20 mg) to High Dose (40 mg) in Patients with Type II Diabetes Mellitus.
Panikar, Vijay; Joshi, Shashank; Tiwaskar, Mangesh; Bhondve, Amit; Nasikkar, Nikhil; Walawalkar, Sanhita; Sachdev, Ishita; Panikar, Krish; Modh, Khushbu; Kulkarni, Pallavi; Medidar, Rahul; Tuteja, Harshpreet; Mansoori, Sana.
Afiliación
  • Panikar V; Consultant, Lilavati Hospital & Research Centre.
  • Joshi S; Consultant, Lilavati Hospital & Research Centre.
  • Tiwaskar M; Consultant Physician and Diabetologist, Shilpa Medical Research Centre.
  • Bhondve A; Consultant, Dr Panikar's Speciality Care Centre.
  • Nasikkar N; Assistant Professor, KJ Somaiya Medical College and Research Centre.
  • Walawalkar S; Consultant, Dr Panikar's Speciality Care Centre.
  • Sachdev I; Student, Dr. Panikar's Speciality Care Centre; 9-13Student, Lilavati Hospital & Research Centre, Mumbai, Maharashtra, India.
  • Panikar K; Student, Dr. Panikar's Speciality Care Centre.
  • Modh K; Student, Lilavati Hospital & Research Centre, Mumbai, Maharashtra, India.
  • Kulkarni P; Student, Lilavati Hospital & Research Centre, Mumbai, Maharashtra, India.
  • Medidar R; Student, Lilavati Hospital & Research Centre, Mumbai, Maharashtra, India.
  • Tuteja H; Student, Lilavati Hospital & Research Centre, Mumbai, Maharashtra, India.
  • Mansoori S; Student, Lilavati Hospital & Research Centre, Mumbai, Maharashtra, India; Corresponding Author.
J Assoc Physicians India ; 70(7): 11-12, 2022 Jul.
Article en En | MEDLINE | ID: mdl-35833400

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV Tipo de estudio: Observational_studies Límite: Female / Humans / Male Idioma: En Revista: J Assoc Physicians India Año: 2022 Tipo del documento: Article Pais de publicación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Inhibidores de la Dipeptidil-Peptidasa IV Tipo de estudio: Observational_studies Límite: Female / Humans / Male Idioma: En Revista: J Assoc Physicians India Año: 2022 Tipo del documento: Article Pais de publicación: India